Association between neurodegenerative plasma biomarkers and geriatric depression in older adults with and without clinical dementia in Kinshasa, Democratic Republic of the Congo - Scorecard - MDSpire

Association between neurodegenerative plasma biomarkers and geriatric depression in older adults with and without clinical dementia in Kinshasa, Democratic Republic of the Congo

  • By

  • Nathan Tsengele

  • Alfred Sodi Magudigana

  • Guy Gikelekele

  • Emmanuel Epenge

  • Guy Kangula

  • Eric Muteba Vukumuna

  • Abraham Mifundu Bilongo

  • Said Mbuku Nguala

  • Degani Banzulu Bomba

  • Gilbert Mananga Lelo

  • Adelin N’situ Mankubu

  • Jean Ikanga

  • May 22, 2026

  • 0 min

Share

Clinical Scorecard: Linking Plasma Biomarkers of Neurodegeneration to Geriatric Depression in Elderly Individuals with and without Clinical Dementia in Kinshasa, Democratic Republic of the Congo

At a Glance

CategoryDetail
Condition
Key MechanismsNeurodegenerative plasma biomarkers including GFAP and NfL (source needed).
Target Population
Care Setting

Key Highlights

  • 80% of participants suspected of having Alzheimer's disease also had geriatric depression (source needed).
  • GFAP and NfL were significantly associated with higher odds of geriatric depression (source needed).
  • Participants with dementia had lower cognitive scores compared to those without dementia (source needed).
  • High blood pressure was common in participants with suspected Alzheimer's disease (source needed).

Guideline-Based Recommendations

Diagnosis

  • Use the Community Dementia Screening Instrument (CSID) and the Alzheimer’s Disease Questionnaire for dementia assessment (source needed).
  • Assess depression using the Geriatric Depression Scale (source needed).

Management

  • Monitor plasma biomarkers such as GFAP and NfL in older adults with depression (source needed).

Monitoring & Follow-up

  • Regular cognitive assessments using the African Neuropsychological Battery (ANB) (source needed).

Risks

  • High prevalence of depression in older adults with dementia (source needed).

Patient & Prescribing Data

Consider the role of neurodegenerative biomarkers in managing geriatric depression (source needed).

Clinical Best Practices

  • Incorporate assessment of neurodegenerative biomarkers in the evaluation of geriatric depression (source needed).
  • Address comorbid conditions such as hypertension in older adults with dementia (source needed).

Related Resources & Content

Original Source(s)

Related Content